对于持续36小时的较大缺血性嗜血症的非手术或手术治疗
Adnan El-Achkar1, Alyssa Arbuiso1, Nilson Marquardt Filho2
1The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 20817, United States.
The journal of sexual medicine
|December 24, 2025
概括
持续超过36小时的缺血性priapism的手术治疗比非手术选择更有效. 手术显著降低了再干预和再接收率,从而改善了患者的治疗结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 手术创新 在外科创新.
背景情况:
- 超过36小时的缺血性青症往往会导致阴茎永久损伤和勃起功能障碍.
- 对于长期缺血性嗜食症进行手术的必要性仍然是一个临床问题.
研究的目的:
- 为了比较持续36小时或更长时间的缺血性priapism手术与非手术治疗的结果.
- 评估治疗组之间的再干预,再接收和并发症率.
主要方法:
- 从2005年到2024年,对76名患有缺血性priapism (持续时间≥36小时) 的患者进行了回顾性审查.
- 患者被分为非手术 (吸血,灌,) 和手术 (转移,假肢) 队列.
- 人口和临床数据使用统计测试 (Wilcoxon-Mann-Whitney,Fisher的确切,奇平方) 进行了分析.
主要成果:
- 与手术组 (10.4%) 相比,非手术组的再入院和再干预率 (66.7%) 显着更高.
- 阴茎纤维化在非手术组 (18.5%) 与手术组 (7.9%) 中发生的频率更高,尽管在统计学上并不显著.
- 基线特征和青症持续时间在两组之间相似.
结论:
- 长期缺血性嗜食症的非手术治疗与失败和并发症率的增加有关.
- 早期的手术干预似乎更有效地改善结局并减少缺血性priapism的发病率>36小时.
- 外科手术方法可能为管理复杂的缺血性priapism病例提供更明确的解决方案.
相关概念视频
Aneurysm III: Interprofessional Care
235
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
235
Angina IV: Management
214
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
214
Pericarditis III: Medical Management
276
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
276
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
527
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
527
Peripheral Artery Disease III: Interprofessional Care
217
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
217
Aneurysm IV: Nursing Management
350
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
350


